healthcare life sciences

Healthcare & life sciences

Select your office

New GDP guidelines: looking beyond

Regulatory changes of Good Distribution Practice (GDP) of Medicinal Products increase complexity

In 2013, the EU-guidelines on GDP of Medicinal Products for Human Use have been augmented: Now for example, the required storage conditions of pharmaceuticals are to be maintained during transportation. In addition, new requirements apply concerning cleanliness and security of any intermediate...
Healthcare & life sciences

Launch excellence for new medicines

Global challenges require new approach for market entry

After years of low productivity, R&D in leading pharmaceutical and biotech companies is starting to deliver on its promises and the number of New Molecular Entities (NMEs) approved by the US FDA has leveled out. Once approval has been gained there needs to be a launch. However, complexity of...
Healthcare & life sciences

Controlling healthcare costs by improving the productivity of medical service

Rising patient expectations, an aging population and often a shortage of medical staff are combining to create a major cost challenge in healthcare. We explain how healthcare service providers can meet this challenge by improving productivity in the crucial area of the medical clinic. We show how...
Healthcare & life sciences, Operations management

Putting patients at the centre of a new biopharma business model

The pharmaceutical industry is suffering. Expiring patents, increasing demands from regulators and decreasing healthcare budgets are putting companies under pressure, and the industry has to walk a narrow tightrope between keeping profitability up and quickly developing attractive medications. As...
Healthcare & life sciences

Mid-Life Crisis: New Challenges in Pharmaceutical Life-Cycle Management

The pharmaceutical industry is in crisis. Big, profitable products are losing their patent protection and generic producers are jumping in to take a growing share of the market. We look at how the big pharmas, and the smaller ones, can find a way through these troubled times.
Chemicals, Healthcare & life sciences

Viewpoint The Nutraceuticals Industry: Harnessing Convergence to Create

The nutraceuticals business has experienced tremendous growth over the past few years and is currently estimated to exceed $65 billion a year in global sales. The term "nutraceutical" is used to describe any food, or part of a food, that offers a medical or health benefit beyond simple nutrition....
Chemicals, Healthcare & life sciences

A Conversation Scott Aviation Makes a Case for Outsourcing R&D

Scott Aviation is a leading U.S. supplier of protective respiratory devices and emergency oxygen equipment. Scott has recently experienced a significant turnaround in its performance, thanks to new product introductions. These new products were created both through internal efforts and through...
Healthcare & life sciences, Strategy